<unk>  is an<unk>  antineoplastic agent that is FDA approved for the treatment of acute lymphoblastic leukemia (ALL) as a component of a multi-agent chemotherapeutic regimen for patients who have developed hypersensitivity to E. coli-derived<unk> .   Common adverse reactions include Diarrhea, elevated levels of transaminase & lactic acid dehydrogenase, fever, injection site reaction.
Asparaginase Erwinia chrysanthemi
Sacrosidase
Agalsidase beta
Glycoprotein 2-beta-D-xylosyltransferase
Formiminotransferase cyclodeaminase
Clostridiopeptidase
Glucuronosyltransferase
Xylosylprotein 4-beta-galactosyltransferase 